{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:57:08Z","timestamp":1775005028097,"version":"3.50.1"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.critrevonc.2022.103605","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T18:32:57Z","timestamp":1642876377000},"page":"103605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Salivary gland cancer in the setting of tumor microenvironment: Translational routes for therapy"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3464-8879","authenticated-orcid":false,"given":"Luccas","family":"Lavareze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Figueira","family":"Scarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reydson Alcides","family":"de Lima-Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Emerick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00edsa","family":"Sales de S\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iara Gon\u00e7alves","family":"Aquino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia Maria","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayara Trevizol","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"My N.","family":"Helms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albina","family":"Altemani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika Said Abu","family":"Egal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3694-5025","authenticated-orcid":false,"given":"Fernanda Viviane","family":"Mariano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2022.103605_bib0005","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.3390\/app10186312","article-title":"A perspective on biotribology in arthroplasty: from in vitro toward the accurate in silico wear prediction","volume":"10","author":"Affatato","year":"2020","journal-title":"Appl. Sci."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.0105-2896.2010.00908.x","article-title":"Cytotoxic and non-cytotoxic roles of the CTL\/NK protease granzyme B","volume":"235","author":"Afonina","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0015","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.7150\/thno.42986","article-title":"The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities","volume":"10","author":"Alame","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12967-019-1985-1","article-title":"PCR-based zebrafish model for personalised medicine in head and neck cancer","volume":"17","author":"Al-Samadi","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0025","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2559.2005.02157.x","article-title":"Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression","volume":"46","author":"Altemani","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/BCTT.S175360","article-title":"Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches","volume":"11","author":"Ayoub","year":"2019","journal-title":"Breast Cancer Targets Ther. Volume"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12105-012-0405-0","article-title":"Salivary mucoepidermoid carcinoma: a multi-institutional review of 76 patients","volume":"7","author":"Bai","year":"2013","journal-title":"Head Neck Pathol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-0038-1660846","article-title":"CXCR4 and PD-1 expression in head and neck Cancer with perineural spread","volume":"80","author":"Barnett","year":"2019","journal-title":"J. Neurol. Surg. B. Skull Base"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0045","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/000348949009901015","article-title":"Histopathologic grading of salivary gland neoplasms: I. Mucoepidermoid carcinomas","volume":"99","author":"Batsakis","year":"1990","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0050","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ijc.31353","article-title":"A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from the Netherlands","volume":"143","author":"Boon","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00020840-200404000-00013","article-title":"Adenoid cystic carcinoma of the head and neck: a review","volume":"12","author":"Bradley","year":"2004","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0060","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/00000478-200107000-00001","article-title":"Mucoepidermoid carcinoma","volume":"25","author":"Brandwein","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0065","series-title":"World Health Organization Classification of Tumours","first-page":"163","article-title":"Mucoepidermoid carcinoma","author":"Brandwein-Gensler","year":"2017"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0070","series-title":"Light-activation of Cre Recombinase in Zebrafish Embryos Through Genetic Code Expansion","first-page":"265","author":"Brown","year":"2019"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0075","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/17460441.2017.1297416","article-title":"Zebrafish xenograft models of cancer and metastasis for drug discovery","volume":"12","author":"Brown","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0080","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.neo.2018.05.009","article-title":"Cooperation between pten and Smad4 in murine salivary gland tumor formation and progression","volume":"20","author":"Cao","year":"2018","journal-title":"Neoplasia (United States)"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0085","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.2147\/OTT.S134589","article-title":"Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors","volume":"10","author":"Chang","year":"2017","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0090","doi-asserted-by":"crossref","first-page":"11410","DOI":"10.1038\/s41598-017-11764-2","article-title":"A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0095","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/s41388-017-0104-0","article-title":"CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells","volume":"37","author":"Chen","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0100","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1158\/1078-0432.CCR-08-0245","article-title":"Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model","volume":"14","author":"Choi","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0105","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/COC.0000000000000429","article-title":"Pembrolizumab for the treatment of advanced salivary gland carcinoma","volume":"41","author":"Cohen","year":"2018","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0110","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.drudis.2012.02.003","article-title":"Predictive in vivo animal models and translation to clinical trials","volume":"17","author":"Cook","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ebiom.2019.02.011","article-title":"Serial patient-derived orthotopic xenografting of adenoid cystic carcinomas recapitulates stable expression of phenotypic alterations and innervation","volume":"41","author":"Cornett","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0120","doi-asserted-by":"crossref","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0125","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1177\/0194599816659257","article-title":"Pretreatment neutrophil-lymphocyte ratio in salivary gland tumors is associated with malignancy","volume":"155","author":"Damar","year":"2016","journal-title":"Otolaryngol. - Head Neck Surg. (United States)"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bjorl.2014.07.016","article-title":"Clinicopathological characteristics and perineural invasion in adenoid cystic carcinoma: a systematic review","volume":"81","author":"Dantas","year":"2015","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0135","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1158\/0008-5472.CAN-04-4041","article-title":"Salivary gland tumors in transgenic mice with targeted PLAG1 proto-oncogene overexpression","volume":"65","author":"Declercq","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0140","doi-asserted-by":"crossref","DOI":"10.1038\/ncponc1237","article-title":"In silico cancer modeling: is it ready for prime time?","author":"Deisboeck","year":"2009","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0145","doi-asserted-by":"crossref","first-page":"9143","DOI":"10.1158\/0008-5472.CAN-10-1758","article-title":"Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of Apc and Pten in the mouse salivary gland: implications for human acinic cell carcinoma","volume":"70","author":"Diegel","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0150","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/hed.23925","article-title":"Adenoid cystic carcinoma: a review of recent advances, molecular targets, and clinical trials","volume":"38","author":"Dillon","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng.3502","article-title":"An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma","volume":"48","author":"Drier","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0160","doi-asserted-by":"crossref","DOI":"10.1002\/wsbm.75","article-title":"In silico models of cancer","author":"Edelman","year":"2010","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0165","series-title":"WHO Classification of Head and Neck Tumours","author":"El-Naggar","year":"2017"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0170","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.6083","article-title":"NISCAHN: a phase II, multicenter nonrandomized trial aiming at evaluating nivolumab (N) in two cohorts of patients (pts) with recurrent\/metastatic (R\/M) salivary gland carcinoma of the head and neck (SGCHN), on behalf of the Unicancer Head & Neck Grou","volume":"37","author":"Fayette","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0175","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41568-020-0252-3","article-title":"Zebrafish patient avatars in cancer biology and precision cancer therapy","volume":"20","author":"Fazio","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0180","doi-asserted-by":"crossref","first-page":"13347","DOI":"10.1038\/srep13347","article-title":"Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype","volume":"5","author":"Fu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s004280050317","article-title":"Reconstruction of pleomorphic adenoma of the salivary glands in three-dimensional collagen gel matrix culture","volume":"434","author":"Fujita","year":"1999","journal-title":"Virchows Arch."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0190","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1186\/s12885-019-5925-5","article-title":"NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12\/CXCR4 pathway","volume":"19","author":"Gao","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0195","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.21.00449","article-title":"Management of salivary gland malignancy: ASCO guideline","volume":"39","author":"Geiger","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0200","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3390\/cancers13040669","article-title":"Drug combination in Cancer treatment\u2014from cocktails to conjugated combinations","volume":"13","author":"Gilad","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"Pt 1","key":"10.1016\/j.critrevonc.2022.103605_bib0205","first-page":"279","article-title":"Malignant mixed tumors of the salivary glands: a review","volume":"28","author":"Gnepp","year":"1993","journal-title":"Pathol. Annu."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0210","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1217::AID-CNCR2>3.0.CO;2-C","article-title":"Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria","volume":"82","author":"Goode","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0215","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nm.3853","article-title":"Translational value of mouse models in oncology drug development","volume":"21","author":"Gould","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0220","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/jop.12458","article-title":"Current management of the neck in salivary gland carcinomas","volume":"46","author":"Green","year":"2017","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0225","article-title":"Therapeutic implications of immune-profiling and EGFR expression in salivary gland carcinoma","author":"Guazzo","year":"2020","journal-title":"Head Neck"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0230","first-page":"3600","article-title":"Metformin inhibits salivary adenocarcinoma growth through cell cycle arrest and apoptosis","volume":"5","author":"Guo","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0235","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0240","first-page":"18","article-title":"PD-L1 expression in malignant salivary gland tumors","author":"Harada","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0245","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3390\/genes10110935","article-title":"Zebrafish models of Cancer\u2014new insights on modeling human Cancer in a non-mammalian vertebrate","volume":"10","author":"Hason","year":"2019","journal-title":"Genes (Basel)."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0250","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/cancers13050965","article-title":"Tumour-infiltrating lymphocytes (TILs) and PD-L1 expression correlate with lymph node metastasis, high-grade transformation and shorter metastasis-free survival in patients with acinic cell carcinoma (AciCC) of the salivary glands","volume":"13","author":"Hiss","year":"2021","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0255","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12885-018-4350-5","article-title":"The oncogenic effects of HES1 on salivary adenoid cystic carcinoma cell growth and metastasis","volume":"18","author":"Huang","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0260","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.it.2016.04.010","article-title":"Targeted therapy and checkpoint immunotherapy combinations for the treatment of Cancer","volume":"37","author":"Hughes","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0265","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1002\/cncr.21116","article-title":"Clinical and immunohistologic typing of salivary duct carcinoma","volume":"103","author":"Jaehne","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0270","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/hed.23350","article-title":"Survival rates and prognostic factors for infiltrating salivary duct carcinoma: analysis of 228 cases from the Surveillance, Epidemiology, and End Results database","volume":"36","author":"Jayaprakash","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0275","doi-asserted-by":"crossref","first-page":"25506","DOI":"10.18632\/oncotarget.4635","article-title":"Thioredoxin 1 mediates TGF-$\u03b2$-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma","volume":"6","author":"Jiang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0280","doi-asserted-by":"crossref","first-page":"E820","DOI":"10.1002\/hed.24107","article-title":"Salivary duct carcinoma: treatment, outcomes, and patterns of failure","volume":"38","author":"Johnston","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0285","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/his.12488","article-title":"Prognostic features in mucoepidermoid carcinoma of major salivary glands with emphasis on tumour histologic grading","volume":"65","author":"Katabi","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0290","doi-asserted-by":"crossref","first-page":"137","DOI":"10.15252\/emmm.201606857","article-title":"Genetically engineered mouse models in oncology research and cancer medicine","volume":"9","author":"Kersten","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0295","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1158\/1078-0432.CCR-17-3871","article-title":"Salivary gland Cancer Patient-Derived xenografts enable characterization of Cancer stem cells and new gene events associated with tumor progression","volume":"24","author":"Keysar","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0300","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/15419061.2018.1464000","article-title":"Establishment and characterization of a carcinoma-associated fibroblast cell line derived from a human salivary gland adenoid cystic carcinoma","volume":"24","author":"Kong","year":"2018","journal-title":"Cell Commun. Adhes."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0305","first-page":"1","article-title":"Immunotherapy in HER2-Positive breast Cancer: a systematic review","author":"Kyriazoglou","year":"2021","journal-title":"Breast Care"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0310","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/emm.2005.48","article-title":"Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells","volume":"37","author":"Lee","year":"2005","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0315","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1053\/hupa.2001.25000","article-title":"Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases","volume":"32","author":"Lewis","year":"2001","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0320","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1002\/cncr.26740","article-title":"A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the surveillance, epidemiology, and end results registry","volume":"118","author":"Li","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0325","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.oraloncology.2014.06.012","article-title":"Development and characterization of salivary adenoid cystic carcinoma cell line","volume":"50","author":"Li","year":"2014","journal-title":"Oral Oncol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0330","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/2468-5585.200513","article-title":"The cross-contaminated cell lines of adenoid cystic carcinoma: a crucial concern","volume":"2","author":"Liu","year":"2017","journal-title":"Transl. Surg."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0335","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.otot.2018.06.001","article-title":"Pathology of benign and malignant neoplasms of salivary glands","volume":"29","author":"Lubin","year":"2018","journal-title":"Oper. Tech. Otolaryngol. Neck Surg."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0340","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0304-3835(92)90044-V","article-title":"Early and multifocal tumors in breast, salivary, Harderian and epididymal tissues developed in MMTY-Neu transgenic mice","volume":"64","author":"Lucchini","year":"1992","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0345","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/02841860802183604","article-title":"Carcinoma ex pleomorphic adenoma of the parotid gland. Study and implications for diagnostics and therapy","volume":"48","author":"L\u00fcers","year":"2009","journal-title":"Acta Oncol. (Madr)."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0350","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20180939","article-title":"Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma","volume":"215","author":"Mandelbaum","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0355","doi-asserted-by":"crossref","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","author":"Mantovani","year":"2008","journal-title":"Nature."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0360","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ijom.2013.02.012","article-title":"Carcinoma ex pleomorphic adenoma in a Brazilian population: clinico-pathological analysis of 38 cases","volume":"42","author":"Mariano","year":"2013","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0365","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1002\/cncr.26697","article-title":"Prognostic factors in mucoepidermoid carcinoma of the salivary glands","volume":"118","author":"McHugh","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0370","doi-asserted-by":"crossref","first-page":"22822","DOI":"10.18632\/oncotarget.4477","article-title":"Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma","volume":"6","author":"Mochizuki","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0375","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.archoralbio.2017.07.004","article-title":"Immunohistochemical investigations on the expression of programmed cell death ligand 1, human leukocyte antigens G and E, and granzyme B in intraoral mucoepidermoid carcinoma","volume":"83","author":"Mosconi","year":"2017","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0380","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.oraloncology.2018.11.028","article-title":"Immune microenvironment and evasion mechanisms in adenoid cystic carcinomas of salivary glands","volume":"88","author":"Mosconi","year":"2019","journal-title":"Oral Oncol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0385","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/labinvest.2011.105","article-title":"Development and characterization of xenograft model systems for adenoid cystic carcinoma","volume":"91","author":"Moskaluk","year":"2011","journal-title":"Lab. Investig."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0390","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jso.24266","article-title":"Programmed death ligand-1 expression is associated with poor disease free survival in salivary gland carcinomas","volume":"114","author":"Mukaigawa","year":"2016","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0395","series-title":"World Health Organization Classification of Tumours","first-page":"173","article-title":"Salivary duct carcinoma","author":"Nagao","year":"2017"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0400","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/cncy.22288","article-title":"Salivary duct carcinoma: updates in histology, cytology, molecular biology, and treatment","volume":"128","author":"Nakaguro","year":"2020","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0405","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.oraloncology.2019.01.015","article-title":"Prognostic value of programed death ligand-1 and ligand-2 co-expression in salivary gland carcinomas","volume":"90","author":"Nakano","year":"2019","journal-title":"Oral Oncol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0410","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/0022034520965141","article-title":"mTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer, Stem Cells","volume":"100","author":"Nakano","year":"2021","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0415","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/cncr.23825","article-title":"Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma","volume":"113","author":"Nance","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0420","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","article-title":"Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway","volume":"21","author":"Ohaegbulam","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0425","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/hed.1100","article-title":"Carcinoma ex pleomorphic adenoma: a clinicopathologic review","volume":"23","author":"Olsen","year":"2001","journal-title":"Head Neck"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0430","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/217370a0","article-title":"Absence of Thymus in a mouse mutant","volume":"217","author":"Pantelouris","year":"1968","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0435","first-page":"701","article-title":"Recapitulating orthotopic tumor model through establishment of a parotid gland tumor with lung metastasis using HeLa cell injection into nude mice","volume":"23","author":"Park","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0440","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.18632\/oncotarget.6919","article-title":"Patient-derived xenograft (PDX) tumors increase growth rate with time","volume":"7","author":"Pearson","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0445","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jormas.2020.06.003","article-title":"Mucoepidermoid carcinoma. An update and review of the literature","volume":"121","author":"Peraza","year":"2020","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0450","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13046-016-0462-4","article-title":"Patient-derived xenografts: a relevant preclinical model for drug development","volume":"35","author":"Pompili","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0455","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.3390\/cancers12113107","article-title":"Molecular and cellular modelling of salivary gland tumors open new landscapes in diagnosis and treatment","volume":"12","author":"Porcheri","year":"2020","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0460","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0465","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1158\/1078-0432.CCR-19-2214","article-title":"A phase II trial of pembrolizumab and vorinostat in recurrent metastatic head and neck squamous cell carcinomas and salivary gland Cancer","volume":"26","author":"Rodriguez","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0470","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1038\/s41388-019-0776-8","article-title":"Non-murine models to investigate tumor-immune interactions in head and neck cancer","volume":"38","author":"Rossa","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103087","article-title":"Head and neck cancer patient-derived xenograft models \u2013 a systematic review","volume":"155","author":"Schuch","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0480","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12105-009-0102-9","article-title":"An update on grading of salivary gland carcinomas","volume":"3","author":"Seethala","year":"2009","journal-title":"Head Neck Pathol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0485","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.path.2016.11.004","article-title":"Salivary gland tumors","volume":"10","author":"Seethala","year":"2017","journal-title":"Surg. Pathol. Clin."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0490","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/odi.13475","article-title":"Mouse parotid salivary gland organoids for the in vitro study of stem cell radiation response","volume":"27","author":"Serrano Martinez","year":"2021","journal-title":"Oral Dis."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0495","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0092-8674(87)90449-1","article-title":"Coexpression of MMTV\/v-Ha-ras and MMTV\/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo","volume":"49","author":"Sinn","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0500","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0002-9610(78)90262-3","article-title":"Mucoepidermoid carcinoma of salivary gland origin","volume":"136","author":"Spiro","year":"1978","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0505","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1158\/2326-6066.CIR-16-0031","article-title":"Immune profiling of adenoid cystic carcinoma: PD-L2 expression and associations with tumor-infiltrating lymphocytes","volume":"4","author":"Sridharan","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0510","series-title":"World Health Organization Classification of Tumours","first-page":"164","article-title":"Adenoid cystic carcinoma","author":"Stenman","year":"2017"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0515","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-4608(90)90008-X","article-title":"Pleomorphic adenomas with unbalanced chromosomal abnormalities have an increased in vitro lifetime","volume":"46","author":"Stern","year":"1990","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0520","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1073\/pnas.2536479100","article-title":"In silico dissection of cell-type-associated patterns of gene expression in prostate cancer","volume":"101","author":"Stuart","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0525","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1124\/jpet.110.167692","article-title":"Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase","volume":"334","author":"Sun","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0530","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/1097-0142(19840915)54:6<1062::AID-CNCR2820540622>3.0.CO;2-E","article-title":"Histologic grading of adenoid cystic carcinoma of the salivary glands","volume":"54","author":"Szanto","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0535","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ijc.33315","article-title":"Establishment of PDX \u2010derived salivary adenoid cystic carcinoma cell lines using organoid culture method","volume":"148","author":"Takada","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0540","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1200\/JCO.18.00545","article-title":"Phase II trial of trastuzumab and docetaxel in patients with human epidermal growth factor receptor 2-Positive salivary duct carcinoma","volume":"37","author":"Takahashi","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0545","doi-asserted-by":"crossref","first-page":"59023","DOI":"10.18632\/oncotarget.19812","article-title":"Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification","volume":"8","author":"Takase","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0550","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/pin.12947","article-title":"In vitro three-dimensional culture systems of salivary glands","volume":"70","author":"Tanaka","year":"2020","journal-title":"Pathol. Int."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0555","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.6084","article-title":"A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent\/metastatic adenoid cystic carcinoma (R\/M ACC)","volume":"37","author":"Tchekmedyian","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0560","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrclinonc.2012.61","article-title":"Patient-derived tumour xenografts as models for oncology drug development","volume":"9","author":"Tentler","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2015.11.001","article-title":"Extracellular matrix structure","author":"Theocharis","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0570","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.4049\/jimmunol.1403134","article-title":"Tumor-infiltrating dendritic cells in Cancer pathogenesis","volume":"194","author":"Tran Janco","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0575","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0092-8674(88)90220-6","article-title":"Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice","volume":"55","author":"Tsukamoto","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0580","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0585","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/hed.26081","article-title":"Central pathology review of salivary gland adenoid cystic carcinoma","volume":"42","author":"Ueda","year":"2020","journal-title":"Head Neck"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0590","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/ijc.30279","article-title":"Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib","volume":"139","author":"von M\u00e4ssenhausen","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0595","first-page":"8","article-title":"TrkB-targeted therapy for mucoepidermoid carcinoma","author":"VP","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0600","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.oraloncology.2013.08.004","article-title":"Characterization of tumorigenic cell lines from the recurrence and lymph node metastasis of a human salivary mucoepidermoid carcinoma","volume":"49","author":"Warner","year":"2013","journal-title":"Oral Oncol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0605","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.oraloncology.2018.10.012","article-title":"UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line","volume":"87","author":"Warner","year":"2018","journal-title":"Oral Oncol."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/4350783","article-title":"Knockdown of matrix metallopeptidase 9 inhibits metastasis of oral squamous cell carcinoma cells in a zebrafish xenograft model","volume":"2020","author":"Wen","year":"2020","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0615","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0620","series-title":"World Health Organization Classification of Head and Neck Tumours","first-page":"176","article-title":"Carcinoma ex pleomorphic adenoma","author":"Williams","year":"2017"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0625","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3892\/or.2015.4390","article-title":"Type III TGF-\u03b2 receptor inhibits cell proliferation and migration in salivary glands adenoid cystic carcinoma by suppressing NF-\u03baB signaling","volume":"35","author":"Xu","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.critrevonc.2022.103605_bib0630","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/his.13944","article-title":"The immune microenvironment and expression of PD-L1, PD-1, PRAME and MHC I in salivary duct carcinoma","volume":"75","author":"Xu","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0635","series-title":"Creation of PDX-Bearing Humanized Mice to Study Immuno-oncology","first-page":"241","author":"Yao","year":"2019"},{"key":"10.1016\/j.critrevonc.2022.103605_bib0640","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.tibs.2018.09.004","article-title":"Biochemical aspects of PD-L1 regulation in Cancer immunotherapy","volume":"43","author":"Zhang","year":"2018","journal-title":"Trends Biochem. Sci."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822000294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822000294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:43:00Z","timestamp":1760902980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842822000294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":128,"alternative-id":["S1040842822000294"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103605","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salivary gland cancer in the setting of tumor microenvironment: Translational routes for therapy","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103605"}}